| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/05/2011 | CA2439099C Anti-platelet and anti-thrombotic agents |
| 06/30/2011 | WO2011079051A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | WO2011078700A1 Topical oral gel formulations for dental use |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011077800A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
| 06/30/2011 | WO2011077158A1 Anticoagulant compounds and their use |
| 06/30/2011 | WO2011077067A1 Polymer conjugates of non-glycosylated erythropoietin |
| 06/30/2011 | WO2011075958A1 Use of toll-like receptor-3 agonist in the preparation of medicament for promoting wound healing |
| 06/30/2011 | WO2011075805A1 Non-toxic and biodegradable insecticide formulation |
| 06/30/2011 | US20110162094 Modified human factor vii/viia and pharmaceutical composition containing the same |
| 06/30/2011 | US20110162092 Composition comprised of akap12 and uses of akap12 mutant zebrafish as an animal model |
| 06/30/2011 | US20110160845 Drug delivery system and method of manufacturing thereof |
| 06/30/2011 | US20110160310 Tcb based hydrophilic polyurethane dispersions |
| 06/30/2011 | US20110160307 Compositions and Methods for Treating Hemorrhagic Conditions |
| 06/30/2011 | US20110160292 Regulation of Integrin Surface Expression |
| 06/30/2011 | US20110160257 Novel salts and polymorphs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 06/30/2011 | US20110160250 Crystalline forms of a factor xa inhibitor |
| 06/30/2011 | US20110160227 Prolyl Hydroxylase Inhibitors |
| 06/30/2011 | US20110160196 Factor xa inhibitors |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160161 Concentrated therapeutic phospholipid compositions |
| 06/30/2011 | US20110160154 Substituted piperazines |
| 06/30/2011 | US20110160130 Cancer treatment method |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159116 Biocompatible materials for medical devices |
| 06/30/2011 | US20110159082 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 06/30/2011 | US20110159053 Preparation of a cell concentrate from a physiological solution |
| 06/30/2011 | US20110159044 Silver ion delivery platform |
| 06/30/2011 | US20110159006 Use of anti-factor xi antibodies for prevention of thrombus formation |
| 06/30/2011 | US20110158996 Von willebrand factor specific binders and methods of use therefor |
| 06/30/2011 | CA2786950A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | CA2785541A1 Anticoagulant compounds and their use |
| 06/29/2011 | EP2338976A1 Lactic acid bacterium having high oxalic acid decomposition ability |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338897A1 Peptides and compounds that bind to a thrombopoietin receptor |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP2338519A1 Agent for treating myelofibrosis |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338495A1 Iron bis-glycinate chelate for use in the oral treatment of anemia in patients with celiac disease |
| 06/29/2011 | EP2337573A1 Whey and thymus function |
| 06/29/2011 | EP1124567B2 Buffered compositions for dialysis |
| 06/29/2011 | CN102112489A Anti-HEPCIDIN-25 selective antibodies and uses thereof |
| 06/29/2011 | CN102112157A Conjugated proteins with prolonged in vivo efficacy |
| 06/29/2011 | CN102112131A Methods of treating thalassemia |
| 06/29/2011 | CN102108351A Low-immunogenicity staphylokinase mutant and preparation method and use thereof |
| 06/29/2011 | CN102108346A Method for preparing lysozyme |
| 06/29/2011 | CN102107006A Coupling medicament for treating diabetes mellitus and medicinal application thereof |
| 06/29/2011 | CN102107000A Application of cholecystokinin octapeptide in pharmacy |
| 06/29/2011 | CN102106964A Medicament for treating anemia |
| 06/29/2011 | CN102106914A Medicament for treating infectious diseases, preparation method and application thereof |
| 06/29/2011 | CN102106907A Quality control method for rhubarb (traditional Chinese medicine) ethanol-extraction process |
| 06/29/2011 | CN102106831A 地西他滨冻干制剂及其制备方法 Decitabine lyophilized formulation and preparation method |
| 06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
| 06/29/2011 | CN102106817A Pre-emulsified propylgallate concentrate and preparation thereof |
| 06/29/2011 | CN102106809A Solid preparation of clopidogrel and preparation method thereof |
| 06/29/2011 | CN102106806A Method for preparing solid preparation and solid preparation |
| 06/29/2011 | CN102106420A Method for processing camellia nitidissima granules |
| 06/29/2011 | CN101869645B Jinkui kidney qi-replenishing traditional Chinese medicine solid oral preparation and preparation method thereof |
| 06/29/2011 | CN101862415B Health liquor |
| 06/29/2011 | CN101810783B Chinese medicinal preparation for curing cerebral hemorrhage |
| 06/29/2011 | CN101700326B Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria |
| 06/29/2011 | CN101647781B Preparation method of ligustrazine phosphate powder injection |
| 06/29/2011 | CN101507738B Preparation method of Shu Xuening injection |
| 06/29/2011 | CN101357198B Traditional Chinese medicine for treating cerebral thrombus |
| 06/29/2011 | CN101301314B Technique for producing liver extract |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968546 Pyridazinone kinase inhibitors |
| 06/28/2011 | US7968542 Thiophene compounds and thrombopoietin receptor activators |
| 06/28/2011 | US7968336 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 06/28/2011 | US7968088 Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
| 06/28/2011 | CA2393042C Antithrombotic compound |
| 06/28/2011 | CA2377909C Pharmaceutical composition containing fenofibrate and preparation method |
| 06/23/2011 | WO2011075596A1 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 06/23/2011 | WO2011074658A1 Novel anti-platelet agent |
| 06/23/2011 | WO2011072482A1 Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
| 06/23/2011 | WO2011072393A1 Decellularized adipose tissue |
| 06/23/2011 | WO2010144502A9 Growth hormone polypeptides and methods of making and using same |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152504 CD16A Binding Proteins and Use for the Treatment of Immune Disorders |
| 06/23/2011 | US20110152304 Spiroazaindoles |
| 06/23/2011 | US20110152298 Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents |
| 06/23/2011 | US20110152273 Fused heteroaromatic pyrrolidinones |
| 06/23/2011 | US20110152259 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152202 Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 06/23/2011 | US20110152193 Inhibitors of human plasmin derived from the kunitz domains |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152168 Antiadhesive carbohydrates |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151011 Decellularized Adipose Tissue |
| 06/23/2011 | US20110151007 Carbide-derived-carbon-based oxygen carriers |
| 06/23/2011 | US20110150976 Transdermal delivery of oligosaccharides |
| 06/23/2011 | US20110150973 Electrospun dextran fibers and devices formed therefrom |
| 06/23/2011 | US20110150972 Medical devices having improved performance |
| 06/23/2011 | US20110150888 Anti-hepcidin antibodies and methods of use |
| 06/23/2011 | US20110150885 Aminoacyl trna synthetases for modulating hematopoiesis |